GGPL-I Antibodies

Santa Cruz Biotechnology offers a broad range of GGPL-I monoclonal antibodies for research applications. GGPL-I monoclonal antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GGPL-I, or Glycosylated GTPase-activating protein, plays a crucial role in cellular signaling pathways and influences various physiological processes. GGPL-I is actively involved in cell growth, differentiation, and apoptosis regulation, making it a significant target for cancer research and other disease studies. Understanding GGPL-I function can reveal new therapeutic strategies and disease mechanisms. Researchers can utilize GGPL-I monoclonal antibodies to explore protein expression patterns across different cell types and tissues. Advanced detection methods using horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates enable precise visualization of GGPL-I localization and interactions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular processes and disease mechanisms.